How I treat inhibitors in haemophilia

16Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The management of patients with inhibitors is the greatest challenge facing haemophilia health professionals. Immune tolerance induction (ITI) can be successful in eliminating the inhibitor in the majority of patients, provided it is started soon after the inhibitor develops and the titre of the inhibitor is <10 BU at commencement of ITI. Acute bleeding is treated using one of two bypassing agents, which exhibit similar efficacy and safety. Surgery in inhibitor patients is challenging and should only be carried out in experienced centres. © 2012 Blackwell Publishing Ltd.

Cite

CITATION STYLE

APA

Makris, M., Hay, C. R. M., Gringeri, A., & D’Oiron, R. (2012). How I treat inhibitors in haemophilia. Haemophilia, 18(SUPPL.4), 48–53. https://doi.org/10.1111/j.1365-2516.2012.02829.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free